Black Deal 12 months of Premium for €49.99 instead of €74.99 12 months €49.99 instead of €74.99 until Sun, Dec 13
Get the deal

Vladosmlt16 - FACEIT level 6, 1,206 ELO

USA
On FACEIT since 2025 231 matches tracked 34 matches in 30 days
Last updated:

Vladosmlt16 at a glance

Level 6 1,206 ELO best map Nuke (73%)
Level 6

Last 20 matches compared with 2,996 players in this group: K/R, ADR and win rate below average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 5%
0.80
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.21 ConsistencyShare of matches with a rating of 0.90 or higher. 40%
K/R
0.59
better than 6% of players
Level 6 avg: 0.70
Last 12 months
ADR
66.4
better than 5% of players
Level 6 avg: 77.5
Last 12 months
Win rate
40%
better than 20% of players
Level 6 avg: 44%
Last 12 months

Facts

145 ELO Next goal That is 3 to 6 wins.
4 W · 2 L Best day +113 ELO · Sep 6, 2026
4 Comebacks last 90 days
Mirage Favorite map 70 of 231 matches
Nuke 73% Map pool tip weakest: Inferno 27%
17:00-1:00 Playing times On Saturdays
12:00-18:00 Best time 64% win rate vs. 50%
FormMapsTiming

145 ELO away from level 7. That is 3 to 6 wins. 4:2 on Sep 6, 2026 (+113 ELO, last 90 days). 4 wins after trailing at halftime (last 90 days). Most played: Mirage (70 of 231 matches). Strongest map: Nuke (73% win rate, 11 matches). Weakest: Inferno (27%, 15 matches). Plays most on Saturdays between 17:00 and 1:00 (based on 231 matches). Best results between 12:00 and 18:00: 64% win rate vs. 50% overall (47 matches).

About Vladosmlt16

Vladosmlt16 plays CS2 on FACEIT level 6 with 1,206 ELO. The stats cover 231 matches. The strongest map is Nuke with a 73% win rate in 11 matches. Most played: Mirage with 70 matches and a 47% win rate. Vladosmlt16 won 4 matches after trailing at halftime (last 90 days). Last 20 matches: 8 wins, 12 losses, -151 ELO. Vladosmlt16 does best between 12:00 and 18:00: 64% win rate in 47 matches.